Breast Cancer Clinical Trial

The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients

Summary

The goal of this study is to determine if acupuncture improves multiple symptoms associated with chemotherapy on the MD Anderson Symptom Inventory (MDASI): nausea, vomiting, fatigue, anxiety, anorexia, pain, disturbed sleep, shortness of breath, dry mouth, depression, and peripheral neuropathy (see statistical section). The investigators hypothesis is that acupuncture will result in lower MDASI scores over the course of chemotherapy for the acupuncture group vs. control group.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years or older
English speaking/reading/writing
Breast cancer stages I through III
Any performance status suitable for chemotherapy as determined by the physician
Primary or secondary chemotherapy, but enrolling patients prior to a chemotherapy regimen regardless of previous radiation therapy exposure and/or previous mastectomy.
Scheduled to receive either of the following two regimens:
Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)
Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)
Taxotere (75mg/m2), Cytoxan (600 mg/m2)
Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose, followed by 420 mg maintenance fixed dose)

Exclusion Criteria:

History of narcolepsy
Sleep apnea requiring continuous positive airway pressure (CPAP)
Other acupuncture treatment within one month of enrollment
Acupuncture treatment for chemotherapy in the past
Current participation in any other research studies

Study is for people with:

Breast Cancer

Estimated Enrollment:

10

Study ID:

NCT01996410

Recruitment Status:

Terminated

Sponsor:

OhioHealth

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Columbus Oncology and Hematology Associates
Columbus Ohio, 43214, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

10

Study ID:

NCT01996410

Recruitment Status:

Terminated

Sponsor:


OhioHealth

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider